Business Description
Jaguar Health Inc
NAICS : 325412
SIC : 2834
ISIN : US47010C7065
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.35 | |||||
Equity-to-Asset | 0.22 | |||||
Debt-to-Equity | 2.79 | |||||
Debt-to-EBITDA | -1.06 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -9.24 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -79.9 | |||||
3-Year EBITDA Growth Rate | 79.2 | |||||
3-Year EPS without NRI Growth Rate | 79.5 | |||||
3-Year FCF Growth Rate | 74.3 | |||||
3-Year Book Growth Rate | -87.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 21.06 | |||||
9-Day RSI | 32.74 | |||||
14-Day RSI | 39.83 | |||||
6-1 Month Momentum % | -5.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.89 | |||||
Quick Ratio | 1.39 | |||||
Cash Ratio | 0.66 | |||||
Days Inventory | 1497.7 | |||||
Days Sales Outstanding | 54.26 | |||||
Days Payable | 818.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -433.9 | |||||
Shareholder Yield % | -133.35 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.07 | |||||
Operating Margin % | -318.44 | |||||
Net Margin % | -377.95 | |||||
FCF Margin % | -298.97 | |||||
ROE % | -612.09 | |||||
ROA % | -73.52 | |||||
ROIC % | -87.2 | |||||
ROC (Joel Greenblatt) % | -322.46 | |||||
ROCE % | -108.97 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.26 | |||||
PB Ratio | 1.6 | |||||
EV-to-EBIT | -1.24 | |||||
EV-to-EBITDA | -1.33 | |||||
EV-to-Revenue | 4.16 | |||||
EV-to-FCF | -1.4 | |||||
Earnings Yield (Greenblatt) % | -80.43 | |||||
FCF Yield % | -148.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Jaguar Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 9.378 | ||
EPS (TTM) (€) | -69.761 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 39.83 | ||
14-Day ATR (€) | 0.899527 | ||
20-Day SMA (€) | 10.988999 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 3.059999 - 25.319999 | ||
Shares Outstanding (Mil) | 4.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jaguar Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jaguar Health Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Jaguar Health Inc Frequently Asked Questions
What is Jaguar Health Inc(HAM:1JA)'s stock price today?
When is next earnings date of Jaguar Health Inc(HAM:1JA)?
Does Jaguar Health Inc(HAM:1JA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |